Demonstration of the lapachol as a potential drug for reducing cancer metastasis

Ilana Teruszkin Balassiano1, Sheila Alves De Paulo, Nathalie Henriques Silva

  • 1Instituto de Biofísica Carlos Chagas Filho, Laboratório de Controle da Expressão Gênica, Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde, Bloco C, Cidade Universitária, CEP 21949-900, Rio de Janeiro, RJ, Brasil.

Oncology Reports
|January 12, 2005
PubMed

Insights

Lapachol shows potential in fighting cancer metastasis. This natural compound alters protein profiles and inhibits HeLa cell invasiveness without affecting viability, offering a promising avenue for new antineoplastic drugs.

Area of Science:

  • Oncology
  • Pharmacology
  • Cell Biology

Background:

  • Metastasis is a primary cause of cancer-related mortality.
  • Developing effective antineoplastic drugs to combat metastasis is a critical research area.
  • Lapachol is a natural compound being investigated for its anti-cancer properties.

Purpose of the Study:

  • To investigate the molecular and morphological effects of lapachol on HeLa cells.
  • To assess lapachol's impact on the invasive properties of cancer cells.
  • To evaluate lapachol as a potential therapeutic agent against metastasis.

Main Methods:

  • HeLa cells were treated with varying concentrations of lapachol.
  • Analysis included cellular protein profiling, morphological examination, and invasiveness assays.
  • The Chorioallantoic Membrane (CAM) model was used to study invasiveness.

Main Results:

  • Lapachol treatment at 400 microg/ml did not alter HeLa cell viability.
  • Significant changes in the cellular protein profile were observed.
  • Lapachol effectively inhibited the invasiveness of HeLa cells in the CAM model.

Conclusions:

  • Lapachol demonstrates potential as an anti-metastatic agent.
  • The compound's ability to inhibit invasiveness warrants further investigation for cancer therapy.
  • Lapachol may offer a novel strategy to combat cancer spread.

Related Concept Videos